Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Jan 20, 2022 7:45pm
RE:RE:RE:RE:RE:RE:Another SVA reviewed publication!!
...not to mention you're tarring Witkowski with the same brush, which also strikes me as weird. But hey, carry on with your soft bash.
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Jan 20, 2022 7:33pm
RE:RE:RE:RE:RE:Another SVA reviewed publication!!
Really Bio? So the President & CEO of the company sponsering the study is "heavily involved" in choosing the patient(s)? That would be just plain weird and probably unethical.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 20, 2022 6:53pm
RE:RE:RE:RE:Another SVA reviewed publication!!
Many have been identified. None have been selected. Do some DD Instead of nitpicking at who's responsible for the physical searching. I'm sure Phil is heavily involved. Fluff news as per usual
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Jan 20, 2022 5:21pm
RE:RE:RE:Another SVA reviewed publication!!
Good point, Mercury. But to further clarify, Sernova's January 10 news release states: "A seventh study patient has been identified."
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Jan 20, 2022 4:55pm
RE:RE:Another SVA reviewed publication!!
Get it into human trials. Oh we can't because spill is still looking for patient 7. No he's not. That trial's run by Dr. Witkowski who designed the study protocol. Phil's the
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 20, 2022 8:54am
RE:Another SVA reviewed publication!!
Nothing wrong with a good fluffing everyday but this is hardly that. There isn't much in here that wasnt presented at the end of the hemacure project over a year ago. Get it into human trials. Oh
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Post by
Stockfshr
on Jan 20, 2022 7:30am
Sernova Announces Peer Reviewed Publication
Sernova Announces Peer Reviewed Publication Demonstrating Safety and Efficacy of a Novel Cell Pouch Cell Therapy Approach for Treatment of Severe Hemophilia A https://sernova.com/press/release/?id
...more
(134)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Jan 20, 2022 7:29am
Another SVA reviewed publication!!
More good news, but some might call it fluff. I say gimme good fluff everyday so we can be in the news. https://sernova.com/press/release/?id=329&s=09
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Jan 20, 2022 12:26am
RE:RE:RE:RE:RE:Insiders
Ekenbullets you won't see insider buying before a deal. It would be disappointing to see insider buying right now. They have enough exposure most of the insider buying was years ago Philip did
...more
(12)
•••
Ekenbullets
X
View Profile
View Bullboard History
Comment by
Ekenbullets
on Jan 19, 2022 10:12pm
RE:RE:RE:RE:Insiders
When nobody or few puts in their own money its usually a big warning sign. Maybe less so here but still I would like to see more insiders buying.
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jan 19, 2022 7:01pm
RE:RE:RE:RE:Insiders
You hit the nail on the head stock Fisher. They are swimming in free paper. Maybe even drowning in it.
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Jan 19, 2022 4:09pm
RE:RE:RE:Insiders
According to InkResearch, there has been no insider buying in the last twelve months. But then why would insiders buy shares when they can get all they want through company granting of options
...more
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Jan 19, 2022 4:01pm
RE:RE:RE:Insiders
Ekenbullets: Looking at the SEDI filings may make the numbers seem unimpressive but that's because you're viewing it piecemeal. Actual holdings of common shares, DSUs, and Options tell a
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Jan 19, 2022 1:04pm
RE:RE:RE:RE:RE:RE:And today we're mentioned in the Globe and Mail
Frauulein smokes a lot of crack. I would not rely on her predictions.
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >